Fair point. I just see this as a wage paying capital raise. Why can they not get decent financing? Thats the questIon that's should be asked
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025